查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1595685

RSV 診斷市場：按產品、方法和最終用途分類 - 全球預測 2025-2030

RSV Diagnostics Market by Product (Instruments, Kits & Assays), Methods (Molecular Diagnostics, Rapid Antigen Detection Tests), End-use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023 年 RSV 診斷市值為 10.7 億美元，預計到 2024 年將達到 11.7 億美元，複合年成長率為 9.20%，到 2030 年將達到 19.8 億美元。

呼吸道融合細胞病毒(RSV) 診斷在醫療保健中至關重要，因為它影響嬰幼兒、老年人和免疫力缺乏。調查方法範圍涵蓋多種測試技術，例如快速抗原檢測測試 (RADT)、分子診斷（例如 RT-PCR）和血清學測定。它們在 RSV 感染的早期檢測和管理、減少 RSV 感染的傳播和嚴重程度方面發揮著至關重要的作用。由於全球對病毒感染的認知不斷提高以及就地檢驗技術的進步，對 RSV 診斷的需求激增。最終使用範圍主要包括醫院、診斷實驗室和診所，高效、快速的決策對於病患照護至關重要。由於RSV流行率上升、對分散診斷解決方案的需求不斷成長以及醫療保健基礎設施的進步等因素，預計該市場將成長。然而，先進診斷工具的高成本、可變的測試靈敏度和監管障礙等挑戰可能會阻礙成長。開發具有成本效益且靈敏的替代診斷工具以及整合人工智慧以提高 RSV 檢測的準確性和效率方面存在機會。公司可以透過投資技術主導的產品開發並擴展到醫療保健需求迅速成長的高成長新興市場來利用這些機會。研究和創新可以集中在增強分子診斷、開發攜帶式照護現場設備以及探索用於預測診斷的生物資訊學。儘管前景廣闊，但該市場仍面臨許多限制，例如來自非專利診斷的競爭、潛在的生物安全問題以及低收入地區的經濟限制。對公司的策略建議包括與醫療保健提供者夥伴關係進行更廣泛的產品部署、專注於研究和開發以推動創新，以及透過策略規劃確保遵守不斷變化的法規。 RSV 診斷市場的本質是動態的，個人化醫療保健解決方案的趨勢凸顯了持續調整和創新的需求。

主要市場統計
基準年[2023] 10.7億美元
預測年份 [2024] 11.7億美元
預測年份 [2030] 19.8億美元
複合年成長率（%） 9.20%

市場動態：揭示快速發展的 RSV 診斷市場的關鍵市場洞察

RSV 診斷市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 人群呼吸道感染疾病盛行率上升
    • 提高感染疾病早期診斷意識
    • 合胞病毒診斷的核准增加
  • 市場限制因素
    • 與 RSV 診斷相關的產品召回問題
  • 市場機會
    • 呼吸道融合細胞病毒診斷研究進展
    • 基因組學和蛋白​​質組學研究的成長
  • 市場挑戰
    • 與目前 RSV 診斷產品和程序相關的限制

波特五力：駕馭 RSV 診斷市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解 RSV 診斷市場的外部影響

外部宏觀環境因素在塑造 RSV 診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解 RSV 診斷市場的競爭狀況

對 RSV 診斷市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的見解，以應對日益激烈的競爭。

FPNV 定位矩陣 RSV 診斷市場供應商的績效評估

FPNV定位矩陣是評估RSV診斷市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

制定 RSV 診斷市場成功之路的策略分析和建議

對於旨在加強在全球市場的影響力的公司來說，RSV 診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人群中呼吸道感染疾病盛行率增加
      • 提高感染疾病早期診斷意識
      • 合胞病毒診斷產品的核准增加
    • 抑制因素
      • 與呼吸道融合病毒（RSV）診斷產品相關的產品召回問題
    • 機會
      • 呼吸道融合病毒（RSV）診斷的進展
      • 基因組學和蛋白​​質組學研究的成長
    • 任務
      • 與目前 RSV 診斷產品和程序相關的限制
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章 RSV 診斷市場：依產品

  • 裝置
  • 套件和檢測

第 7 章 RSV 診斷市場（依方法）

  • 分子診斷
  • 抗原快速檢測試驗

第 8 章 RSV 診斷市場：依最終用途分類

  • 居家護理
  • 醫院/診所

第9章 美洲RSV診斷市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太地區RSV診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章 歐洲、中東和非洲RSV診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • Altona Diagnostics GmbH
  • Atlas Medical GmbH
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • bioMerieux SA
  • BTNX Inc.
  • CerTest Biotec SL
  • CTK Biotech, Inc.
  • Danaher Corporation
  • DiaSorin SpA
  • F. Hoffmann-La Roche Ltd.
  • Hologic, Inc.
  • Merck KGaA
  • Meridian Bioscience, Inc.
  • Pro-Lab Diagnostics Inc.
  • Qiagen GmbH
  • Quidel Corporation
  • SA Scientific, Ltd.
  • Sansure Biotech Inc.
  • Sentinel Ch SpA
  • Serion GmbH
  • Siemens Healthcare GmbH
  • Thermo Fisher Scientific Inc.
  • Vela Diagnostics Holding Pte Ltd.
  • Virax Biolabs Group Limited
  • Weldon Biotech, Inc.
Product Code: MRR-C002B1C99841

The RSV Diagnostics Market was valued at USD 1.07 billion in 2023, expected to reach USD 1.17 billion in 2024, and is projected to grow at a CAGR of 9.20%, to USD 1.98 billion by 2030.

Respiratory Syncytial Virus (RSV) diagnostics are crucial in the healthcare landscape due to the virus's impact on infants, elderly, and immunocompromised individuals. The scope of RSV diagnostics encompasses diverse testing methodologies such as rapid antigen detection tests (RADTs), molecular diagnostics like RT-PCR, and serological assays. These play a pivotal role in early detection and management, thereby reducing the transmission and severity of RSV infections. The necessity of RSV diagnostics has surged, driven by increasing global awareness about viral infections and advancements in point-of-care testing technologies. End-use scopes primarily involve hospitals, diagnostic laboratories, and clinics, where efficient and quick decisions are vital for patient care. The market is poised for growth due to factors such as rising RSV prevalence, growing demand for decentralized diagnostic solutions, and advancements in healthcare infrastructure. However, challenges including high costs of advanced diagnostic tools, variability in test sensitivity, and regulatory hurdles can impede growth. Opportunities exist in the development of cost-effective, highly sensitive diagnostic alternatives and the integration of artificial intelligence to enhance accuracy and efficiency of RSV tests. Companies can capitalize on these opportunities by investing in technology-driven product development and expanding into high-growth emerging markets with burgeoning healthcare needs. Research and innovation can focus on enhancing molecular diagnostics, developing portable point-of-care devices, and exploring bioinformatics for predictive diagnostics. Despite the promising outlook, the market faces limitations such as competition from generic diagnostic methods, potential biosafety issues, and economic constraints in low-income regions. Strategic recommendations for businesses include forming partnerships with healthcare providers for broader product reach, focusing on R&D to drive innovation, and ensuring compliance with evolving regulations through strategic planning. The nature of the RSV diagnostics market is dynamic, with a trend towards personalized healthcare solutions, emphasizing the need for continual adaptation and innovation.

KEY MARKET STATISTICS
Base Year [2023] USD 1.07 billion
Estimated Year [2024] USD 1.17 billion
Forecast Year [2030] USD 1.98 billion
CAGR (%) 9.20%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving RSV Diagnostics Market

The RSV Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of respiratory infections among population
    • Growing awareness about early diagnosis of infectious diseases
    • Increasing approvals for syncytial virus diagnostic product
  • Market Restraints
    • Product recall issues associated with RSV diagnostic products
  • Market Opportunities
    • Advancements in respiratory syncytial virus diagnosis
    • Growth in genomics and proteomics research
  • Market Challenges
    • Limitations associated with current RSV diagnostic products and procedures

Porter's Five Forces: A Strategic Tool for Navigating the RSV Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the RSV Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the RSV Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the RSV Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the RSV Diagnostics Market

A detailed market share analysis in the RSV Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the RSV Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the RSV Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the RSV Diagnostics Market

A strategic analysis of the RSV Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the RSV Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Altona Diagnostics GmbH, Atlas Medical GmbH, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, BTNX Inc., CerTest Biotec S.L., CTK Biotech, Inc., Danaher Corporation, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd., Hologic, Inc., Merck KGaA, Meridian Bioscience, Inc., Pro-Lab Diagnostics Inc., Qiagen GmbH, Quidel Corporation, SA Scientific, Ltd., Sansure Biotech Inc., Sentinel Ch S.p.A., Serion GmbH, Siemens Healthcare GmbH, Thermo Fisher Scientific Inc., Vela Diagnostics Holding Pte Ltd., Virax Biolabs Group Limited, and Weldon Biotech, Inc..

Market Segmentation & Coverage

This research report categorizes the RSV Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Instruments and Kits & Assays.
  • Based on Methods, market is studied across Molecular Diagnostics and Rapid Antigen Detection Tests.
  • Based on End-use, market is studied across Home Care and Hospital & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of respiratory infections among population
      • 5.1.1.2. Growing awareness about early diagnosis of infectious diseases
      • 5.1.1.3. Increasing approvals for syncytial virus diagnostic product
    • 5.1.2. Restraints
      • 5.1.2.1. Product recall issues associated with RSV diagnostic products
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in respiratory syncytial virus diagnosis
      • 5.1.3.2. Growth in genomics and proteomics research
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations associated with current RSV diagnostic products and procedures
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. RSV Diagnostics Market, by Product

  • 6.1. Introduction
  • 6.2. Instruments
  • 6.3. Kits & Assays

7. RSV Diagnostics Market, by Methods

  • 7.1. Introduction
  • 7.2. Molecular Diagnostics
  • 7.3. Rapid Antigen Detection Tests

8. RSV Diagnostics Market, by End-use

  • 8.1. Introduction
  • 8.2. Home Care
  • 8.3. Hospital & Clinics

9. Americas RSV Diagnostics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific RSV Diagnostics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa RSV Diagnostics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Altona Diagnostics GmbH
  • 3. Atlas Medical GmbH
  • 4. Becton, Dickinson and Company
  • 5. Bio-Rad Laboratories, Inc.
  • 6. bioMerieux SA
  • 7. BTNX Inc.
  • 8. CerTest Biotec S.L.
  • 9. CTK Biotech, Inc.
  • 10. Danaher Corporation
  • 11. DiaSorin S.p.A.
  • 12. F. Hoffmann-La Roche Ltd.
  • 13. Hologic, Inc.
  • 14. Merck KGaA
  • 15. Meridian Bioscience, Inc.
  • 16. Pro-Lab Diagnostics Inc.
  • 17. Qiagen GmbH
  • 18. Quidel Corporation
  • 19. SA Scientific, Ltd.
  • 20. Sansure Biotech Inc.
  • 21. Sentinel Ch S.p.A.
  • 22. Serion GmbH
  • 23. Siemens Healthcare GmbH
  • 24. Thermo Fisher Scientific Inc.
  • 25. Vela Diagnostics Holding Pte Ltd.
  • 26. Virax Biolabs Group Limited
  • 27. Weldon Biotech, Inc.

LIST OF FIGURES

  • FIGURE 1. RSV DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. RSV DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL RSV DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. RSV DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. RSV DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. RSV DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL RSV DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. RSV DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY RAPID ANTIGEN DETECTION TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY HOME CARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL RSV DIAGNOSTICS MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 28. CANADA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 31. MEXICO RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 34. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES RSV DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 36. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 38. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 40. AUSTRALIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. AUSTRALIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 42. AUSTRALIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 43. CHINA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CHINA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 45. CHINA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 46. INDIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. INDIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 48. INDIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 49. INDONESIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. INDONESIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 51. INDONESIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 52. JAPAN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. JAPAN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 54. JAPAN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. MALAYSIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. MALAYSIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 57. MALAYSIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 58. PHILIPPINES RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. PHILIPPINES RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 60. PHILIPPINES RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 61. SINGAPORE RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. SINGAPORE RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 63. SINGAPORE RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 64. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 65. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 66. SOUTH KOREA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 67. TAIWAN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. TAIWAN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 69. TAIWAN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 70. THAILAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. THAILAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 72. THAILAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 73. VIETNAM RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. VIETNAM RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 75. VIETNAM RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 76. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 77. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 78. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA RSV DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 80. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 82. DENMARK RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 83. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 85. EGYPT RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 86. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 88. FINLAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 89. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 91. FRANCE RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 94. GERMANY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 95. ISRAEL RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. ISRAEL RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 97. ISRAEL RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 98. ITALY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. ITALY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 100. ITALY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 101. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 102. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 103. NETHERLANDS RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 104. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 106. NIGERIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. NORWAY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. NORWAY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 109. NORWAY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 110. POLAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. POLAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 112. POLAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 113. QATAR RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 114. QATAR RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 115. QATAR RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 116. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 117. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 118. RUSSIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 119. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 121. SAUDI ARABIA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 124. SOUTH AFRICA RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 125. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 127. SPAIN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 128. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 129. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 130. SWEDEN RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 131. SWITZERLAND RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. SWITZERLAND RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 133. SWITZERLAND RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 134. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 135. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 136. TURKEY RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 137. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 138. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 139. UNITED ARAB EMIRATES RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY METHODS, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED KINGDOM RSV DIAGNOSTICS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. RSV DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 144. RSV DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023